Call & WhatsApp: +91-73375-30225
24/7 Email: bonhoahealth@gmail.com
New product
Warning: Last items in stock!
Availability date:
Hepcdac(Daclatasvir 60mg), is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection.
Limitations of Use: Sustained virologic response (SVR12) rates are reduced in genotype 3 patients with cirrhosis receiving Daclatasvir 60mg in combination with sofosbuvir for 12 weeks.
Hepcdac is a generic oncologic prescription medicine from Cipla, which is one of the biggest pharmaceutical company in India.
Package Quantity | 28 |
Warnings | Don't take the drug without consulting a qualified doctor or physician |
Suggested use | Follow the doctor's advice |
Delivery & Returns | 10-20 days |
$164.00
$137.00
$108.00
$145.00
Sofosbuvir 400mg
$108.00
Very Excited
I take the genric Deklenza and Savodi together once a day and genotype 3A. I've had a few side effects that's listed but nothing that I can't deal with. The most Bothersome side effects for me is it feels like my insides are slightly burning. Three weeks after taking these medications together my RNA came back less than 15 so I'm completing this course I'm very excited.